- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 27.02. | UK M&A activity down in January amid uncertain US opportunities | ||
| 27.02. | Mandatory drug stock monitoring empowers EU to tackle shortages | ||
| 27.02. | SCOPE 2025: investors share optimism and obstacles for AI in clinical operations | ||
| 27.02. | Pfizer's bet on gene therapies in haemophilia has been a bust | ||
| 27.02. | Vietnam eases foreign investment restrictions in amended pharmaceutical law | ||
| 27.02. | IPA and Ribopro form mRNA antibody discovery collaboration | ||
| 27.02. | NICE approval of Casgevy: a new era for sickle cell disease treatments in the UK | ||
| 27.02. | Regeneron makes second bid for blood cancer therapy approval | ||
| 27.02. | FDA grants fast track status to Pyxis' PYX-201 | ||
| 27.02. | Eli Lilly to expand US pharma manufacturing with four new sites | ||
| 26.02. | Magazine: Radiopharmaceutical deals drive sector growth despite supply crisis | ||
| 26.02. | Eikon raises almost $351m to advance cancer candidates through the clinic | ||
| 26.02. | Emalex eyes FDA approval for Tourette syndrome therapy after Phase III success | ||
| 26.02. | Idorsia's Tryvio deal collapses, forcing company to find cash urgently | ||
| 26.02. | FDA approvals decline but drug innovation remains strong even among small sponsors | ||
| 26.02. | RedHill and Hyloris sign agreement for Bekinda's development | ||
| 26.02. | Eli Lilly pays $10m upfront for Organovo's FXR agonist | ||
| 26.02. | FDA grants breakthrough status to Grin Therapeutics' radiprodil | ||
| 26.02. | Sanofi's Sarclisa combo approved in Japan for newly diagnosed MM | ||
| 25.02. | J&J sues Samsung Bioepis over 'surreptitious' breach of Stelara biosimilar contract | ||
| 25.02. | FDA removes clinical hold on Entrada's Duchenne therapy | ||
| 25.02. | EMA approves Takeda's Takhzyro pre-filled pen option for HAE | ||
| 25.02. | Gilead's lenacapavir applications for HIV gain EMA validation | ||
| 25.02. | Sionna Therapeutics' IPO: A strategic shift in the cystic fibrosis market | ||
| 25.02. | FDA accepts BMS' Opdivo-Yervoy combo sBLA for colorectal cancer |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
